Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-28.62M
↓ 16% vs avg
Percentile
P44
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-24.58M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-28.62M | +25.2% |
| 2024 | $-38.29M | -20.2% |
| 2023 | $-31.85M | -12.4% |
| 2022 | $-28.33M | +2.1% |
| 2021 | $-28.95M | +0.3% |
| 2020 | $-29.03M | -25.7% |
| 2019 | $-23.10M | -25.2% |
| 2018 | $-18.45M | -131.0% |
| 2017 | $-7.99M | +28.6% |
| 2016 | $-11.19M | - |